{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:11:42Z","timestamp":1778224302301,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04933-x","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T07:25:05Z","timestamp":1774855505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: delayed profound hypomagnesemia from carboplatin- associated renal magnesium wasting"],"prefix":"10.1186","volume":"27","author":[{"given":"Louaa","family":"Chebbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaelle","family":"Salame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"issue":"2","key":"4933_CR1","first-page":"47","volume":"24","author":"R Swaminathan","year":"2003","unstructured":"Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev. 2003;24(2):47\u201366. PubMed PMID: 18568054; PubMed Central PMCID: PMC1855626.","journal-title":"Clin Biochem Rev"},{"issue":"1","key":"4933_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00012.2014","volume":"95","author":"JHF De Baaij","year":"2015","unstructured":"De Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium in Man: Implications for Health and Disease. Physiol Rev. 2015;95(1):1\u201346. https:\/\/doi.org\/10.1152\/physrev.00012.2014.","journal-title":"Physiol Rev"},{"issue":"2","key":"4933_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1053\/j.akdh.2022.12.001","volume":"30","author":"EC Ray","year":"2023","unstructured":"Ray EC, Mohan K, Ahmad S, Wolf MTF. Physiology of a Forgotten Electrolyte\u2014Magnesium Disorders. Adv Kidney Dis Health. 2023;30(2):148\u201363. https:\/\/doi.org\/10.1053\/j.akdh.2022.12.001.","journal-title":"Adv Kidney Dis Health"},{"key":"4933_CR4","doi-asserted-by":"publisher","unstructured":"Touyz RM, De Baaij JHF, Hoenderop JGJ. Magnesium disorders. Ingelfinger JR, editor. N Engl J Med. 2024;390(21):1998\u20132009. https:\/\/doi.org\/10.1056\/NEJMra1510603.","DOI":"10.1056\/NEJMra1510603"},{"issue":"4","key":"4933_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11523-011-0200-y","volume":"6","author":"A Costa","year":"2011","unstructured":"Costa A, Tejpar S, Prenen H, Van Cutsem E. Hypomagnesaemia and targeted anti-epidermal growth factor receptor (EGFR) agents. Target Oncol. 2011;6(4):227\u201333. https:\/\/doi.org\/10.1007\/s11523-011-0200-y.","journal-title":"Target Oncol"},{"issue":"5","key":"4933_CR6","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00280-017-3392-8","volume":"80","author":"B Oronsky","year":"2017","unstructured":"Oronsky B, Caroen S, Oronsky A, Dobalian VE, Oronsky N, Lybeck M, et al. Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management. Cancer Chemother Pharmacol. 2017;80(5):895\u2013907. https:\/\/doi.org\/10.1007\/s00280-017-3392-8.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"4933_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/ctrv.1999.0097","volume":"25","author":"H Lajer","year":"1999","unstructured":"Lajer H, Daugaard G. Cisplatin and hypomagnesemia. Cancer Treat Rev. 1999;25(1):47\u201358. https:\/\/doi.org\/10.1053\/ctrv.1999.0097.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"4933_CR8","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/sj.bjc.6690697","volume":"81","author":"MW English","year":"1999","unstructured":"English MW, Skinner R, Pearson ADJ, Price L, Wyllie R, Craft AW. Dose-related nephrotoxicity of carboplatin in children. Br J Cancer. 1999;81(2):336\u201341. https:\/\/doi.org\/10.1038\/sj.bjc.6690697.","journal-title":"Br J Cancer"},{"key":"4933_CR9","doi-asserted-by":"publisher","first-page":"154162","DOI":"10.1016\/j.tox.2025.154162","volume":"515","author":"DA Barnes","year":"2025","unstructured":"Barnes DA, Janssen MJ, Yang H, Redegeld FA, Masereeuw R. An adverse outcome pathway for DNA adduct formation leading to kidney failure. Toxicology. 2025;515:154162. https:\/\/doi.org\/10.1016\/j.tox.2025.154162.","journal-title":"Toxicology"},{"issue":"3","key":"4933_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.phrs.2004.04.001","volume":"50","author":"K Husain","year":"2004","unstructured":"Husain K, Whitworth C, Rybak L. Time response of carboplatin-induced nephrotoxicity in rats. Pharmacol Res. 2004;50(3):291\u2013300. https:\/\/doi.org\/10.1016\/j.phrs.2004.04.001.","journal-title":"Pharmacol Res"},{"issue":"6","key":"4933_CR11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/ajco.13481","volume":"17","author":"G Gaughran","year":"2021","unstructured":"Gaughran G, Qayyum K, Smyth L, Davis A. Carboplatin and hypomagnesemia: Is it really a problem? Asia Pac J Clin Oncol. 2021;17(6):478\u201385. https:\/\/doi.org\/10.1111\/ajco.13481.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"2","key":"4933_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/pbc.20812","volume":"48","author":"W St\u00f6hr","year":"2007","unstructured":"St\u00f6hr W, Paulides M, Bielack S, J\u00fcrgens H, Koscielniak E, Rossi R, et al. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: A report from the late effects surveillance system. Pediatr Blood Cancer. 2007;48(2):140\u20137. https:\/\/doi.org\/10.1002\/pbc.20812.","journal-title":"Pediatr Blood Cancer"},{"key":"4933_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/951768","volume":"2015","author":"S Janett","year":"2015","unstructured":"Janett S, Camozzi P, Peeters GGAM, Lava SAG, Simonetti GD, Goeggel Simonetti B, et al. Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors. Gastroenterol Res Pract. 2015;2015:1\u20137. https:\/\/doi.org\/10.1155\/2015\/951768.","journal-title":"Gastroenterol Res Pract"},{"issue":"11","key":"4933_CR14","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.3390\/cancers14112754","volume":"14","author":"ECM Van Der Kooijmans","year":"2022","unstructured":"Van Der Kooijmans ECM, Van Der Pluijm SMF, Kremer LCM, Bresters D, et al. Long-Term Tubular Dysfunction in Childhood Cancer Survivors; DCCSS-LATER 2 Renal Study. Cancers. 2022;14(11):2754. https:\/\/doi.org\/10.3390\/cancers14112754.","journal-title":"Cancers"},{"issue":"18","key":"4933_CR15","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1016\/j.ejca.2009.06.032","volume":"45","author":"R Skinner","year":"2009","unstructured":"Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson ADJ. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors. Eur J Cancer. 2009;45(18):3213\u20139. https:\/\/doi.org\/10.1016\/j.ejca.2009.06.032.","journal-title":"Eur J Cancer"},{"issue":"2","key":"4933_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/21548331.2017.1286924","volume":"45","author":"M Velimirovic","year":"2017","unstructured":"Velimirovic M, Ziperstein JC, Fenves AZ. A case of chronic hypomagnesemia in a cancer survivor. Hosp Pract. 2017;45(2):58\u201364. https:\/\/doi.org\/10.1080\/21548331.2017.1286924.","journal-title":"Hosp Pract"},{"key":"4933_CR17","doi-asserted-by":"publisher","first-page":"S1106","DOI":"10.1016\/j.annonc.2023.09.895","volume":"34","author":"CEDR Castro","year":"2023","unstructured":"Castro CEDR, Dias F, Dacoregio MI, Michelon IF, Stecca CE, Vilbert MS. 2113P Efficacy and effectiveness of prophylactic magnesium supplementation on prevention of cisplatin-induced nephrotoxicity: A systematic review and meta-analysis. Ann Oncol. 2023;34:S1106. https:\/\/doi.org\/10.1016\/j.annonc.2023.09.895.","journal-title":"Ann Oncol"},{"key":"4933_CR18","doi-asserted-by":"publisher","unstructured":"Kimura T, Ozawa T, Hanai N, Hirakawa H, Suzuki H, Hosoi H, et al. Renal protective effect of a hydration supplemented with magnesium in patients receiving cisplatin for head and neck cancer. J Otolaryngol. 2018;47(1):10. https:\/\/doi.org\/10.1186\/s40463-018-0261-3. PubMed PMID: 29394952; PubMed Central PMCID: PMC5797413.","DOI":"10.1186\/s40463-018-0261-3"},{"issue":"8","key":"4933_CR19","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1007\/s00394-022-03004-9","volume":"61","author":"JHF De Baaij","year":"2022","unstructured":"De Baaij JHF, Bockenhauer D, Claverie-Martin F, Hoenderop JGJ, Hoorn EJ, Houillier P, et al. Comment to Recommendation on an updated standardization of serum magnesium reference ranges. Eur J Nutr. 2022;61(8):4231\u20133. https:\/\/doi.org\/10.1007\/s00394-022-03004-9.","journal-title":"Eur J Nutr"},{"issue":"2","key":"4933_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1681\/ASN.2014030293","volume":"26","author":"A Blanchard","year":"2015","unstructured":"Blanchard A, Vargas-Poussou R, Vallet M, Caumont-Prim A, Allard J, Desport E, et al. Indomethacin, Amiloride, or Eplerenone for Treating Hypokalemia in Gitelman Syndrome. J Am Soc Nephrol. 2015;26(2):468\u201375. https:\/\/doi.org\/10.1681\/ASN.2014030293.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4933_CR21","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1053\/j.ajkd.2023.11.006","volume":"83","author":"CV Shah","year":"2024","unstructured":"Shah CV, Sparks MA, Lee CT. Sodium\/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis: A Review. Am J Kidney Dis. 2024;83(5):648\u201358. https:\/\/doi.org\/10.1053\/j.ajkd.2023.11.006.","journal-title":"Am J Kidney Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04933-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04933-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04933-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:36:49Z","timestamp":1778222209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04933-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4933"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04933-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki. Ethical approval was not received for this human study because formal ethical committee approval is not required for single case reports.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient was fully conscious, oriented, and demonstrated intact decision-making capacity. She was verbally informed in detail about the nature and purpose of the publication, and she provided oral consent after explanation of the matter. Written informed consent for publication of the case details and accompanying images was obtained from the patient\u2019s legal guardian. The consent was signed by her legal guardian solely due to the patient\u2019s physical inability to complete the documentation, not because of any impairment in cognitive capacity.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"296"}}